Sign in
4

Changes in Ownership

Iambic Therapeutics, Inc. Filed Acc 0001323304-26-000010

Options or other derivatives

  • Director acquired 20,300 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
TAGLIAFERRI MARY Director 2026-10-14 Grant or award · 10/14/2026 +20,300 20,300 D
Loading xslF345X06/form4-10162026_081043.xml…